5,421
edits
Ovarian cancer: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 157: | Line 157: | ||
In high-risk patients (BRCA, Lynch syndrome), we can do prophylactic bilateral salpingo-oophorectomy after the age of 35. | In high-risk patients (BRCA, Lynch syndrome), we can do prophylactic bilateral salpingo-oophorectomy after the age of 35. | ||
<section begin="gyntreatment" /><section begin="borderline" /> | <section begin="gyntreatment" /><section begin="borderline" /><section begin="germ cell" /> | ||
== Management == | == Management == | ||
Most patients with epithelial ovarian carcinoma are treated by surgical removal or cytoreduction followed by adjuvant chemotherapy. Borderline tumours are managed like malignant epithelial tumours. | <section end="germ cell" />Most patients with epithelial ovarian carcinoma are treated by surgical removal or cytoreduction followed by adjuvant chemotherapy. Borderline tumours are managed like malignant epithelial tumours. | ||
=== Surgical treatment === | === Surgical treatment === | ||